HK1004523A1 - Use of 5-htia agonists for the manufacture of a medicament protecting against ischaemic damage - Google Patents

Use of 5-htia agonists for the manufacture of a medicament protecting against ischaemic damage

Info

Publication number
HK1004523A1
HK1004523A1 HK98103616A HK98103616A HK1004523A1 HK 1004523 A1 HK1004523 A1 HK 1004523A1 HK 98103616 A HK98103616 A HK 98103616A HK 98103616 A HK98103616 A HK 98103616A HK 1004523 A1 HK1004523 A1 HK 1004523A1
Authority
HK
Hong Kong
Prior art keywords
medicament
manufacture
protecting against
ischaemic damage
htia agonists
Prior art date
Application number
HK98103616A
Other languages
English (en)
Inventor
Charles David Nicholson
Johannes Jukna
Original Assignee
Smithkline Beecham Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Pharma Gmbh filed Critical Smithkline Beecham Pharma Gmbh
Publication of HK1004523A1 publication Critical patent/HK1004523A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
HK98103616A 1988-05-06 1998-04-28 Use of 5-htia agonists for the manufacture of a medicament protecting against ischaemic damage HK1004523A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888810748A GB8810748D0 (en) 1988-05-06 1988-05-06 Novel treatment

Publications (1)

Publication Number Publication Date
HK1004523A1 true HK1004523A1 (en) 1998-11-27

Family

ID=10636459

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98103616A HK1004523A1 (en) 1988-05-06 1998-04-28 Use of 5-htia agonists for the manufacture of a medicament protecting against ischaemic damage

Country Status (6)

Country Link
US (1) US5049588A (xx)
EP (1) EP0345948B1 (xx)
JP (1) JP2717844B2 (xx)
DE (1) DE68908485T2 (xx)
GB (1) GB8810748D0 (xx)
HK (1) HK1004523A1 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3831888A1 (de) * 1988-09-20 1990-03-29 Troponwerke Gmbh & Co Kg Arzneimittel zur behandlung von apoplexia cerebri
US5200410A (en) * 1988-09-20 1993-04-06 Troponwerke Gmbh & Co. Medicaments for the treatment of cerebral apoplexy
US5824680A (en) * 1991-08-31 1998-10-20 Bayer Aktiengesellschaft Ipsapirone for the treatment of alzheimer's disease by improving memory
FR2707636B1 (fr) * 1993-06-29 1995-09-15 Inst Francais Du Petrole Composition sulfo-uréique résultant de l'action de l'urée sur une boue sulfurique d'origine pétrolière, procédé de préparation et utilisation comme source de matière fertilisante.
DE19522088A1 (de) * 1995-06-19 1997-01-02 Bayer Ag Benzisothiazolyl-substituierte Aminomethylchromane
DE10031390A1 (de) * 2000-07-03 2002-01-17 Knoll Ag Pyrimidinderivate und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie
DE10031391A1 (de) * 2000-07-03 2002-02-07 Knoll Ag Bicyclische Verbindungen und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie
DE10109866A1 (de) * 2001-03-01 2002-09-05 Abbott Gmbh & Co Kg Triazolverbindungen und deren Verwendung zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie
DE10109867A1 (de) * 2001-03-01 2002-09-05 Abbott Gmbh & Co Kg Verwendung von Triazolverbindungen zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8004002L (sv) * 1980-05-29 1981-11-30 Arvidsson Folke Lars Erik Terapeutiskt anvendbara tetralinderivat
JPS58500714A (ja) * 1981-05-11 1983-05-06 ア−ヴイツツソン，フオルケ・ラルス−エリ−ク 治療上有用なテトラリン誘導体３、かかる化合物の製法および医薬製剤
DE3430284A1 (de) * 1984-08-17 1986-02-27 Troponwerke GmbH & Co KG, 5000 Köln Neue tryptamin-derivate, ein verfahren zu ihrer herstellung und ihre verwendung
DE3719924A1 (de) * 1986-12-22 1988-06-30 Bayer Ag 8-substituierte 2-aminotetraline

Also Published As

Publication number Publication date
EP0345948A3 (en) 1991-11-06
EP0345948B1 (en) 1993-08-18
DE68908485D1 (de) 1993-09-23
JP2717844B2 (ja) 1998-02-25
US5049588A (en) 1991-09-17
DE68908485T2 (de) 1994-02-03
JPH01319429A (ja) 1989-12-25
GB8810748D0 (en) 1988-06-08
EP0345948A2 (en) 1989-12-13

Similar Documents

Publication Publication Date Title
GB2224134B (en) Protective goggles
ZA896487B (en) Adjuvants for use with crop protection agents
EP0334809A3 (en) Agents for the protection of plants against diseases
HK1004523A1 (en) Use of 5-htia agonists for the manufacture of a medicament protecting against ischaemic damage
IL100195A0 (en) Use of xanthines for the preparation of a medicament having immuno suppressing activity
GB2220556B (en) Head protector
GB2219926B (en) A system for protecting the human body against the effects of acceleration forces
GB2222743B (en) Interferometry
AU8824791A (en) Use of xanthines for the preparation of a medicament effective for inhibiting the effects of allograft reaction in humans
DK159683A (da) Tyverisikringsanlaeg, navnlig til butiksarealer
AU8225391A (en) The use of inositolmonophosphate for the preparing of a medicament effective as a neuropeptide gamma-antagonist
GB9006881D0 (en) Use of a propanol as resist-remover
AU4446889A (en) Ameliorating agent for dysmenesia
GB2251402B (en) Procedure for the manufacture of contour-stable objects
GB2213505B (en) Tape for technical use
GB8925182D0 (en) Lung protecting agents
GB8823092D0 (en) Protective coating
GB8804584D0 (en) Protecting coated surfaces
ZA90498B (en) Use of a polyurethane composition for the protection of surfaces
EP0223701A3 (en) Use of ergoline derivatives in the preparation of a neural protective medicament
PL273119A2 (en) Agent for protecting wood against biocorrosion
IE882467L (en) Pharmaceutical preparation for external use
AU101881S (en) Sprinkler protector
AU101880S (en) Sprinkler protector
GB8830386D0 (en) Protective suit

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20090504